Xeris Biopharma Holdings, Inc.XERSNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
12.00%
↑ 101% vs avg
Percentile
P100
Near historical high
Streak
6 yr
Consecutive growthExpanding
Average
-1025.03%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 12.00% | +274.2% |
| 2024 | -6.89% | +52.4% |
| 2023 | -14.48% | +77.0% |
| 2022 | -62.87% | +72.6% |
| 2021 | -229.21% | +40.8% |
| 2020 | -387.19% | +91.1% |
| 2019 | -4327.59% | -86.4% |
| 2018 | -2321.10% | -36.9% |
| 2017 | -1695.18% | -39.2% |
| 2016 | -1217.77% | - |